期刊文献+

髋关节置换术后感染的微生物特点及药敏分析 被引量:12

Analysis of microbiology and antibiotic susceptibility in 131 cases of prosthetic hip infections
原文传递
导出
摘要 目的对髋关节置换术后进行二期翻修的感染病例进行微生物学和药敏分析。方法选取自2007年1月1日至2013年12月31日解放军总医院骨关节科髋关节置换感染行二期翻修的患者进行回顾性研究,选取术中可疑组织做细菌培养,分析微生物种类、数量及抗生素药敏结果。结果本组患者共131例,术中培养阳性96例,阴性培养率为26.7%。所有感染病例中近50%病例原发病为骨折病例,31.3%的病例之前有过手术史。革兰阳性菌占74.3%,革兰阴性菌占20.2%,真菌占5.5%,混合感染比例为11.5%。凝固酶阴性葡萄球菌(CNS)是检出比例最高的菌株,达到38.53%,其次是金黄色葡萄球菌,占19.3%。耐甲氧西林葡萄球菌(MRS)的检出比例较高,达到29.4%(32/109),占葡萄球菌属的44.4%。革兰阴性菌主要以铜绿假单胞菌和大肠埃希菌为主。真菌感染主要以白色念珠菌为主。混合感染中最常见的菌株是肠球菌。抗生素药敏情况提示:指南推荐的头孢唑啉和头孢呋辛对CNS和MRS耐药情况严重,普通的第三代,第四代头孢对格兰阴性菌耐药较严重。对革兰阳性菌敏感率高的药物有万古霉素,利奈唑胺,利福平,对革兰阴性菌敏感率高的药物有阿米卡星,哌拉西林/他唑巴坦,头孢哌酮/舒巴坦,左氧氟沙星,碳青霉烯类。结论关节置换术后感染的细菌主要由凝固酶阴性葡萄球菌引起,耐甲氧西林葡萄球菌比例较高,经验型用药可以选用万古霉素来覆盖革兰阳性菌,左氧氟沙星,哌拉西林/他唑巴坦(头胞哌酮/舒巴坦)或碳青霉烯类药物来覆盖阴性菌。应当根据药敏结果及时调整抗生素。 Objective To explore the microbiological etiology of prosthetic hip infections during two-staged revision and analyze antibiotic susceptibility of bacteria isolated from infected hip arthroplasty specimens so as to provide clinical recommendations for empiric prophylactic and therapeutic antibiotics therapy. Methods A retrospective review was conducted for hospitalized patients of prothetic hip infections during two-staged revision between January 1, 2007 and December 31, 2013. Suspicious intraoperative tissues were cultured and microbiological data sets and antibiotic susceptibility of bacteria were analyzed. Results A total of 131 patients met the inclusion criteria. Micro-organisms were isolated in 96 patients. The negative culture rate was 26. 7%. Nearly half of primary diseases were of fractures and 31.29% of all infected patients had previous surgery. Gram-positive isolates were the most common genus encountered (n =81, 74. 3% ) , followed by Gram-negative isolates ( n = 22, 20. 2% ) and fungal isolates ( n = 6, 5.5% ). Polymicrobial infections accounted for 11.5%. Coagulase-negative staphylococci was the most common causative organism of infection ( n = 42, 38.5% ) , followed by Staphylococcus aureus ( 19. 3% ). The proportion of isolated methieillin-resistant Staphylococcus was 29.36% for all organisms and 44.4% for Staphylococcus. Gram-negative isolates were dominated by Pseudomonas aeruginosa and Escherichia coll. Fungal isolates were dominated by Candida albicans. Enterococcus was the most common causative organism of polymicrobialinfection. The results of antibiotic susceptibility showed cefazolin and cefuroxime were poorly susceptible to coagulase negative staphylococci (CNS) and methicillin-resistant staphylococcus (MRS). Some third and fourth-generation cephalosporins also had problems of bacterial resistance to Gram-negative isolates. Some antibiotics such as vancomycin, linezolid and rifampin were sensitive to Gram-positive isolates. Some antibiotics such as amikacin piperacillin/tazobactam, cefoperazone/sulbactam, levofloxaeinareand carbapenems were sensitive to Gram-negative isolates. Conclusion Most infections are caused by staphylococci. The proportion of isolated methicillin-resistant Staphylococcus is high. Empiric antibiotics should include vancomycin for Gram-positive organisms and piperacillin/tazobactam (cefoperazone/sulbactam), levofloxaeinare or carbapenems for most Gram-negative bacteria. Antibiotics should be timely adjusted according to the antibiotic susceptibility results.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第21期1657-1660,共4页 National Medical Journal of China
关键词 关节成形术 置换 髋假体 抗药性 微生物 抗生素类 感染 Arthroplasty, replacement, hip Hip, prosthesis Drug resistance, microbial Antibiotics Infection
  • 相关文献

参考文献17

  • 1Workgroup Convened by the Museuloskeletal Infection Society. New definition for periprosthetic joint infection [ J ]. J Arthroplasty ,2011,26 : 1136.
  • 2Trampuz A, Piper KE, Jacobson M J, et al. Sonication of removed hip and knee prostheses for diagnosis of infection [ J ]. N Engl J Med,2007, 357:654-663.
  • 3Bejon P, Berendt A, Atkins BL, et al. Two-stage revision for prosthetic joint infection: predictors of outcome and the role of reimplantation microbiology [ J ]. J Antimicrob Chemother , 2010, 65:569-575.
  • 4Tsai JC, Sheng WH, Lo WY, et al. Clinical characteristics, microbiology, and outcomes of prosthetic joint infection in Taiwan [ J]. J Microbiol Immunol Infect,2013, 21:1-7.
  • 5Moran E, Masters S, Berendt AR, et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention[ J]. J Infect,2007, 55 : 1-7.
  • 6Parvizi J, Ghanem E, Azzam K, et al. Periprosthetic infection : are current treatment strategies adequate [ J ] ? Acta Orthop Belg, 2008, 74:793-800.
  • 7Pulido L, Ghanem E, Joshi A, et al. Periprosthetic joint infection : the incidence, timing, and predisposing factors [ J ]. Clin Orthop Relat Res ,2008, 466 : 1710-1715.
  • 8Rasouli MR, Tripathi MS, Kenyon R, et al. Low rate of infection control in enterococcal periprosthetic joint infections [ J 1. Clin Orthop Relat Res, 2012,470 : 2708.
  • 9Phelan DM, Osmon DR, Keating MR, et al. Delayed reimplantation arthroplasty for candidal prosthetic joint infection : a report of 4 cases and review of the literature[ J]. Clin Infect Dis, 2002, 34 : 930-938.
  • 10Azzam K, Parvizi J, Jungkind D, et al. Microbiological, clinical, and surgical features of fungal prosthetic joint infections : a multi- institutional experience [ J]. J Bone Joint Surg Am, 2009, 91: 142-149.

二级参考文献14

  • 1Trampuz A, Piper KE, Jacobson M J, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med, 2007,357:705 -706.
  • 2Achermann Y, Vogt M, Leunig M, et al. Improved diagnosis of peripmsthetic joint infection by multiplex PCR of sonication fluid from removed implants. Clin Micmbiol,2010,48:1208-1214.
  • 3Rafiq I, Gambhir AK, Wroblewski BM, et al. The microbiology of infected hip arthroplasty. Int Orthop, 2006,30:532-535.
  • 4Carvin KL , Hinfichs SH , Urban JA. Emerging antibiotic resistant bacteria : their treatment in total joint arthroplasty. Clin Orthop , Clin Orthop Relat Res, 1999,369 : 110-123.
  • 5A1Buhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthmplasty: a systematic review. J Bone Joint Surg Br,2008,90:915-919.
  • 6A1-Maiyah M, Hill D, Bajwa A, et al. Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty. J Bone Joint Surg Br,2005,87 : 1256-1258.
  • 7Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am, 2009,91 : 2480- 2490.
  • 8Rybak M, Lomaestro B, Rotsehafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm,2009,66:82-98.
  • 9Perlroth J, Kuo M, Tan J, et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med,2008,168:805-819.
  • 10Berdal JE, Skrtanm I, Mowinckel P, et al. Use of rifampicin and ciprofloxacin combination therapy after surgical debfidement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect,2005,11 : 843-845.

共引文献6

同被引文献103

  • 1郝立波,韩黎,王岩,周勇刚,王继芳,孟玉芬.髋关节置换后感染的微生物学分析和生物被膜研究[J].微生物学通报,2005,32(4):124-128. 被引量:13
  • 2周定球,周淑群,韦叶育,韦柳华,范柳青.人工关节置换术后患者感染生物被膜菌及药敏结果分析[J].中国临床康复,2006,10(41):168-169. 被引量:3
  • 3王娜,刘玉珂,李少侠,刘尚才,宋玉华.人工关节置换术后感染的细菌培养及药敏分析[J].中医正骨,2007,19(1):29-30. 被引量:3
  • 4Workgroup Convened by the Musculoskeletal Infection Society. New definition for periprosthetic joint infection [ J ]. J Arthroplasty, 2011,26 : 1136.
  • 5Chun CH. Diagnosis of infected total knee arthroplasty [ J ]. J Korean Knee Soc ,2009,21:205-211.
  • 6Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection [ J ]. N Engl J Med,2007, 357:654-663.
  • 7Peel TN, Buising KL, Choong PFM. Prosthetic joint infection: challenges of diagnosis and treatment[ J]. ANZ J Surg,2013,81 :32 -39.
  • 8Cho WS, Jeong YG, Park JH ,et al. Treatment of infected TKRA [ J]. J Korean Orthop Assoc,2001,36:561-567.
  • 9Stefansdottir A, Johansson D, Knutson K, et al. Microbiology of the infected knee arthroplasty: report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases[J]. Stand J Infect Dis, 2009,41:831-840.
  • 10Moran E, Masters S, Berendt AR, et al. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by dehridement, irrigation and prosthesis retention[J]. Infect, 2007, 55:1-7.

引证文献12

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部